levodopa/carbidopa high dose (ND0612H) / Mitsubishi Tanabe 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
levodopa/carbidopa high dose (ND0612H) / Mitsubishi Tanabe
BouNDless, NCT04006210 / 2018-004156-37: Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations

Active, not recruiting
3
381
Europe, US, RoW
ND0612 Solution for SC infusion, Placebo for SC infusion, Oral IR-LD/CD, IR-LD/CD, Placebo for Oral IR-LD/CD, Placebo for IR-LD/CD
NeuroDerm Ltd.
Parkinson's Disease
11/22
02/27
BeyoND, NCT02726386 / 2015-005814-31: A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease

Active, not recruiting
2
214
Europe, US, RoW
ND0612, ND0612H
NeuroDerm Ltd.
Parkinson's Disease
09/19
02/27

Download Options